ImmuPharma PLC (IMM) — Cash Flow-to-Debt Ratio
ImmuPharma PLC (IMM) has a Cash Flow-to-Debt Ratio of -0.81x as of June 2025, meaning its operating cash flow of GBX-1.00 Million could theoretically repay -1% of its total liabilities (GBX1.24 Million) in one year. See IMM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ImmuPharma PLC Cash Flow-to-Debt Ratio (2004–2024)
Historical debt coverage capacity for ImmuPharma PLC across 21 annual periods. For the full cash flow conversion analysis, see ImmuPharma PLC (IMM) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for ImmuPharma PLC (2004–2024)
Year-by-year debt coverage analysis for ImmuPharma PLC. Check ImmuPharma PLC (IMM) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.16x | GBX-1.77 Million | GBX1.52 Million | ▼ -42.1% |
| 2023 | -0.82x | GBX-1.36 Million | GBX1.67 Million | ▲ +49.3% |
| 2022 | -1.62x | GBX-2.35 Million | GBX1.45 Million | ▲ +47.0% |
| 2021 | -3.05x | GBX-4.83 Million | GBX1.58 Million | ▼ -15.5% |
| 2020 | -2.64x | GBX-3.33 Million | GBX1.26 Million | ▲ +66.7% |
| 2019 | -7.94x | GBX-4.22 Million | GBX531.87K | ▼ -74.0% |
| 2018 | -4.56x | GBX-4.72 Million | GBX1.03 Million | ▼ -48.9% |
| 2017 | -3.06x | GBX-4.42 Million | GBX1.44 Million | ▲ +45.0% |
| 2016 | -5.57x | GBX-6.49 Million | GBX1.16 Million | ▼ -104.6% |
| 2015 | -2.72x | GBX-4.15 Million | GBX1.52 Million | ▼ -49.5% |
| 2014 | -1.82x | GBX-2.49 Million | GBX1.37 Million | ▲ +16.1% |
| 2013 | -2.17x | GBX-3.91 Million | GBX1.80 Million | ▼ -39.5% |
| 2012 | -1.56x | GBX-3.26 Million | GBX2.09 Million | ▲ +18.0% |
| 2011 | -1.90x | GBX-3.37 Million | GBX1.77 Million | ▲ +56.1% |
| 2010 | -4.33x | GBX-6.84 Million | GBX1.58 Million | ▼ -337.2% |
| 2009 | 1.82x | GBX11.96 Million | GBX6.56 Million | ▲ +253.2% |
| 2008 | -1.19x | GBX-2.57 Million | GBX2.16 Million | ▲ +65.6% |
| 2007 | -3.46x | GBX-3.63 Million | GBX1.05 Million | ▼ -341.9% |
| 2006 | -0.78x | GBX-879.00K | GBX1.12 Million | ▼ -140.6% |
| 2005 | 1.93x | GBX27.00K | GBX14.00K | ▲ +285.7% |
| 2004 | 0.50x | GBX1.00K | GBX2.00K | — |